Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial.

Weintraub WS, Mahoney EM, Zhang Z, Chu H, Hutton J, Buxton M, Booth J, Nugara F, Stables RH, Dooley P, Collinson J, Stuteville M, Delahunty N, Wright A, Flather MD, De Cock E.

Heart. 2004 Jul;90(7):782-8.

3.

Cost-effectiveness analysis for surgical, angioplasty, or medical therapeutics for coronary artery disease: 5-year follow-up of medicine, angioplasty, or surgery study (MASS) II trial.

Vieira RD, Hueb W, Hlatky M, Favarato D, Rezende PC, Garzillo CL, Lima EG, Soares PR, Hueb AC, Pereira AC, Ramires JA, Kalil Filho R.

Circulation. 2012 Sep 11;126(11 Suppl 1):S145-50.

4.

Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina.

Henderson RA, Pocock SJ, Sharp SJ, Nanchahal K, Sculpher MJ, Buxton MJ, Hampton JR.

Lancet. 1998 Oct 31;352(9138):1419-25.

PMID:
9807988
6.

Coronary artery stents: a rapid systematic review and economic evaluation.

Hill R, Bagust A, Bakhai A, Dickson R, Dündar Y, Haycox A, Mujica Mota R, Reaney A, Roberts D, Williamson P, Walley T.

Health Technol Assess. 2004 Sep;8(35):iii-iv, 1-242. Review.

7.

The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.

Zhang Z, Mahoney EM, Spertus JA, Booth J, Nugara F, Kolm P, Stables RH, Weintraub WS.

Am Heart J. 2006 Dec;152(6):1153-60.

PMID:
17161069
8.

Coronary stenting versus coronary bypass surgery in patients with multiple vessel disease and significant proximal LAD stenosis: results from the ERACI II study.

Rodriguez A, Rodríguez Alemparte M, Baldi J, Navia J, Delacasa A, Vogel D, Oliveri R, Fernández Pereira C, Bernardi V, O'Neill W, Palacios IF.

Heart. 2003 Feb;89(2):184-8.

9.

Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial.

Magnuson EA, Farkouh ME, Fuster V, Wang K, Vilain K, Li H, Appelwick J, Muratov V, Sleeper LA, Boineau R, Abdallah M, Cohen DJ; FREEDOM Trial Investigators..

Circulation. 2013 Feb 19;127(7):820-31. doi: 10.1161/CIRCULATIONAHA.112.147488.

10.

Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.

Osnabrugge RL, Magnuson EA, Serruys PW, Campos CM, Wang K, van Klaveren D, Farooq V, Abdallah MS, Li H, Vilain KA, Steyerberg EW, Morice MC, Dawkins KD, Mohr FW, Kappetein AP, Cohen DJ; SYNTAX trial investigators..

Heart. 2015 Dec;101(24):1980-8. doi: 10.1136/heartjnl-2015-307578.

PMID:
26552756
11.

Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.

Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Kim JJ, Choo SJ, Chung CH, Lee JW, Park SW, Park SJ.

J Am Coll Cardiol. 2010 Oct 19;56(17):1366-75. doi: 10.1016/j.jacc.2010.03.097.

13.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

14.

Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.

Reynolds MR, Neil N, Ho KK, Berezin R, Cosgrove RS, Lager RA, Sirois C, Johnson RG, Cohen DJ.

Am Heart J. 2003 Feb;145(2):334-42.

PMID:
12595853
15.

The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trials.

Flather M, Rhee JW, Boothroyd DB, Boersma E, Brooks MM, Carrié D, Clayton TC, Danchin N, Hamm CW, Hueb WA, King SB, Pocock SJ, Rodriguez AE, Serruys P, Sigwart U, Stables RH, Hlatky MA.

J Am Coll Cardiol. 2012 Nov 20;60(21):2150-7. doi: 10.1016/j.jacc.2012.08.982.

17.

Comparing performance between coronary intervention centres requires detailed case-mix adjusted analysis.

Denvir MA, Lee AJ, Rysdale J, Prescott RJ, Eteiba H, Walker A, Starkey IR, Pell JP.

J Public Health (Oxf). 2004 Jun;26(2):177-84.

18.

Comparing cost aspects of coronary artery bypass graft surgery with coronary artery stenting.

Birim Ö, Bogers AJ, Kappetein AP.

J Cardiovasc Surg (Torino). 2012 Oct;53(5):641-50. Review.

PMID:
22252542
19.

Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease.

Legrand VM, Serruys PW, Unger F, van Hout BA, Vrolix MC, Fransen GM, Nielsen TT, Paulsen PK, Gomes RS, de Queiroz e Melo JM, Neves JP, Lindeboom W, Backx B; Arterial Revascularization Therapy Study (ARTS) Investigators..

Circulation. 2004 Mar 9;109(9):1114-20.

20.

Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial.

Cohen DJ, Lavelle TA, Van Hout B, Li H, Lei Y, Robertus K, Pinto D, Magnuson EA, Mcgarry TF, Lucas SK, Horwitz PA, Henry CA, Serruys PW, Mohr FW, Kappetein AP.

Catheter Cardiovasc Interv. 2012 Feb 1;79(2):198-209. doi: 10.1002/ccd.23147.

PMID:
21542113
Items per page

Supplemental Content

Support Center